Hepatitis C: HCV antibodies LIS Code: HCV Ab

Understanding Hepatitis C Virus (HCV)

Hepatitis C virus (HCV), first identified in 1989, is a major global cause of liver disease and a growing public health concern. It is estimated that over 170 million people—approximately 3% of the world’s population—are infected with HCV, many without knowing it.

Challenges in Diagnosing Hepatitis C

HCV often presents without noticeable symptoms, especially in the early stages, making clinical diagnosis difficult. As a result, screening tests play a vital role in identifying infections early and preventing long-term complications such as cirrhosis or liver cancer.

Acute and Chronic Hepatitis C

HCV infection can lead to both acute and chronic forms of hepatitis. While some individuals clear the virus naturally, many progress to chronic infection, which requires monitoring and treatment to prevent severe liver damage.

Role of Anti-HCV Antibody Testing

Anti-HCV antibody tests are essential for detecting past or present infection with the hepatitis C virus. These tests identify antibodies produced by the immune system in response to HCV and are often used in combination with other diagnostics, such as HCV-RNA testing, to confirm active infection.

Screening Blood and Blood Products

Anti-HCV testing is also critical for screening donated blood and blood products to ensure they are not contaminated with the virus, thereby protecting recipients from potential transmission.

Private Hepatitis C Testing in Slough

Private HCV testing is available in Slough and surrounding areas including Windsor, Maidenhead, Langley, and Burnham. Early detection through anti-HCV antibody testing allows for timely medical intervention and improved liver health outcomes for individuals at risk of hepatitis C infection.